Atea Pharmaceuticals Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | – | – | -129.3% | – | – | – | – | |
| – | +0.0% | +11.8% | +52.6% | +796.6% | +60.0% | +0.0% | +0.0% | |
| – | +50.7% | +1,095.0% | +431.3% | +17.9% | +5.8% | +4.7% | -60.0% | |
| – | +50.7% | +1,095.0% | +431.3% | +4.1% | – | – | – | |
| – | -20.1% | +51,748.9% | -182.6% | – | – | -146.3% | – | |
| – | -83.3% | +1,200.0% | -84.6% | +48,475.0% | -100.0% | – | – | |
| – | -83.3% | +1,200.0% | -84.6% | +11,385,150.0% | – | +39.2% | +236.5% | |
| – | – | – | -99.7% | – | – | – | – | |
| – | -100.1% | – | -99.7% | -74.7% | -30.5% | +3.9% | -9,742.3% | |
| – | -165.6% | – | -110.3% | – | – | – | – | |
| – | – | – | -129.3% | – | – | – | – |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.